Task: Answer the multiple-choice question.
Question: Which drug has a 4.120\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
a: Cc1ccc(NC(=O)c2cccc(S(=O)(=O)N3CCCC3)c2)nc1
b: COC(C[C@H](O)C[C@H](O)[C@@H](C)OCc1ccccc1)OC
Answer: a. Cc1ccc(NC(=O)c2cccc(S(=O)(=O)N3CCCC3)c2)nc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1ccc(NC(=O)c2cccc(S(=O)(=O)N3CCCC3)c2)nc1
Cc1ccc(NC(=O)c2cccc(S(=O)(=O)N3CCCC3)c2)nc1
N-(5-methylpyridin-2-yl)-3-pyrrolidin-1-ylsulfonylbenzamide